Established and Emerging Mechanisms of Diabetic Cardiomyopathy

Area of Science:

• Cardiology
• Endocrinology
• Molecular Biology

Background:

• Diabetes mellitus is a significant risk factor for heart failure, independent of other cardiovascular conditions.
• Diabetic cardiomyopathy (DC) presents clinically with cardiac hypertrophy and diastolic dysfunction, leading to heart failure with preserved ejection fraction (HFpEF) and potentially heart failure with reduced ejection fraction (HFrEF).

Purpose of the Study:

• To provide a comprehensive overview of the established molecular mechanisms underlying diabetic cardiomyopathy (DC).
• To discuss novel and emerging mechanisms contributing to the structural and functional alterations in DC.

Main Methods:

• This is a review article, synthesizing existing research on diabetic cardiomyopathy.
• It examines established pathways such as fibrosis, apoptosis, oxidative stress, calcium handling, metabolism, and inflammation.
• It also discusses recent findings on autophagy, microRNAs, epigenetics, and mitochondrial alterations.

Main Results:

• Established mechanisms like myocardial fibrosis, apoptosis, oxidative stress, impaired calcium handling, metabolic shifts, and inflammation are key drivers of DC.
• Emerging mechanisms including autophagy, microRNA dysregulation, epigenetic changes, and mitochondrial dysfunction are increasingly recognized as contributors to DC.
• These molecular alterations collectively lead to cardiac hypertrophy and diastolic dysfunction characteristic of DC.

Conclusions:

• Diabetic cardiomyopathy is a complex condition driven by a multitude of molecular pathways.
• Understanding both established and emerging mechanisms is crucial for developing targeted therapies for DC.
• Further research into novel pathways like mitochondrial alterations and epigenetic modifications holds promise for future interventions.